
Complete Genomics
An established technology leader in whole human genome sequencing.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
$118m Valuation: $118m | Acquisition | ||
Total Funding | 000k |









Related Content
Complete Genomics is a life sciences company that has developed and commercialized a DNA sequencing platform for human genome sequencing and analysis. The company provides comprehensive sequencing solutions catering to both the research and healthcare sectors.
Their core offering is a high-performance sequencing technology with industry-leading accuracy and variant detection. This technology is utilized for whole genome sequencing (WGS), exome sequencing, and other genomic analysis services. The company's business model is centered on the sale of these sequencing solutions and services to a client base that includes research institutions and healthcare providers.
As a subsidiary of MGI, Complete Genomics has a significant U.S. manufacturing footprint and is actively working on diversifying its supply chain and expanding its Next-Generation Sequencing (NGS) capabilities. The company engages in strategic collaborations and partnerships to further its reach and technological advancements in the genomics field.
Keywords: DNA sequencing, human genome, sequencing solutions, life sciences, genomics, whole genome sequencing, variant detection, sequencing technology, MGI, healthcare research